Literature DB >> 30343726

Science-Based Actions Can Help Address the Opioid Crisis.

David H Epstein1, Markus Heilig2, Yavin Shaham3.   

Abstract

The epidemic of addiction and overdose is real. Addiction among pain patients accounts for only a small proportion but a large number. Scientific opinion leaders can be most effective on two fronts, each relatively low-tech: dissemination and oversight of empirically established treatments, and promulgation of social-science-based strategies for population-level prevention. Published by Elsevier Ltd.

Entities:  

Keywords:  addiction treatment; opioid addiction; opioid overdose; prevention; science policy

Mesh：

Year:  2018        PMID： 30343726     DOI： 10.1016/j.tips.2018.06.002

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


  14 in total

1.  Prediction of stress and drug craving ninety minutes in the future with passively collected GPS data.

Authors:  David H Epstein; Matthew Tyburski; William J Kowalczyk; Albert J Burgess-Hull; Karran A Phillips; Brenda L Curtis; Kenzie L Preston
Journal:  NPJ Digit Med       Date:  2020-03-04

2.  Stress, craving and mood as predictors of early dropout from opioid agonist therapy.

Authors:  Leigh V Panlilio; Samuel W Stull; William J Kowalczyk; Karran A Phillips; Jennifer R Schroeder; Jeremiah W Bertz; Massoud Vahabzadeh; Jia-Ling Lin; Mustapha Mezghanni; Edward V Nunes; David H Epstein; Kenzie L Preston
Journal:  Drug Alcohol Depend       Date:  2019-07-16       Impact factor: 4.492

3.  Lack of effect of different pain-related manipulations on opioid self-administration, reinstatement of opioid seeking, and opioid choice in rats.

Authors:  David J Reiner; E Andrew Townsend; Javier Orihuel; Sarah V Applebey; Sarah M Claypool; Matthew L Banks; Yavin Shaham; S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2021-03-25       Impact factor: 4.530

4.  Association of Drug Cues and Craving With Drug Use and Relapse: A Systematic Review and Meta-analysis.

Authors:  Nilofar Vafaie; Hedy Kober
Journal:  JAMA Psychiatry       Date:  2022-07-01       Impact factor: 25.911

Review 5.  Relapse to opioid seeking in rat models: behavior, pharmacology and circuits.

Authors:  David J Reiner; Ida Fredriksson; Olivia M Lofaro; Jennifer M Bossert; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2018-10-06       Impact factor: 7.853

6.  Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky.

Authors:  Kirsten E Smith; Martha D Tillson; Michele Staton; Erin M Winston
Journal:  Drug Alcohol Depend       Date:  2020-01-09       Impact factor: 4.492

7.  Effect of the dopamine stabilizer (-)-OSU6162 on potentiated incubation of opioid craving after electric barrier-induced voluntary abstinence.

Authors:  Ida Fredriksson; Sarah V Applebey; Angelica Minier-Toribio; Aniruddha Shekara; Jennifer M Bossert; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2020-01-06       Impact factor: 7.853

8.  Beyond abstinence and relapse: cluster analysis of drug-use patterns during treatment as an outcome measure for clinical trials.

Authors:  Leigh V Panlilio; Samuel W Stull; Jeremiah W Bertz; Albert J Burgess-Hull; William J Kowalczyk; Karran A Phillips; David H Epstein; Kenzie L Preston
Journal:  Psychopharmacology (Berl)       Date:  2020-09-29       Impact factor: 4.530

9.  A drug-vs-food "choice" self-administration procedure in rats to investigate pharmacological and environmental mechanisms of substance use disorders.

Authors:  E Andrew Townsend; Kathryn L Schwienteck; Hannah L Robinson; Stephen T Lawson; Matthew L Banks
Journal:  J Neurosci Methods       Date:  2021-03-08       Impact factor: 2.390

10.  Mechanistic Understanding of Peptide Analogues, DALDA, [Dmt1]DALDA, and KGOP01, Binding to the mu Opioid Receptor.

Authors:  Maria Dumitrascuta; Marcel Bermudez; Steven Ballet; Gerhard Wolber; Mariana Spetea
Journal:  Molecules       Date:  2020-04-29       Impact factor: 4.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.